Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-02-06

Clinical Trial Update: The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ketamine as an adjuvant therapy for acute status asthmaticus in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Augusta University | Conditions: Status Asthmaticus | Phase 3 | Status: WITHDRAWN